Long-term effect of sulfionylura in permanent neonatal diabetes due to mutations in KCNJ11 encoding kir6.2

被引：0
|
作者：
Njolstad, PR
Abuelo, D
Baevre, H
Hansen, T
Hathout, E
Kirsti, A
Hogasen, M
Molven, A
Pedersen, O
Phutkul, CP
Pontynen, S
Pruhova, S
Raeder, H
Sagen, JV
Shehadeh, N
Silva, JML
Sovik, O
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A293 / A293
页数：1
相关论文
共 50 条
  • [1] Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2 -: Patient characteristics and initial response to sulfonylurea therapy
    Sagen, JV
    Ræder, H
    Hathout, E
    Shehadeh, N
    Gudmundsson, K
    Bævre, H
    Abuelo, D
    Phornphutkul, C
    Molnes, J
    Bell, GI
    Gloyn, AL
    Hattersley, AT
    Molven, A
    Sovik, O
    Njolstad, PR
    DIABETES, 2004, 53 (10) : 2713 - 2718
  • [2] Neonatal diabetes -: The role of KCNJ11 (Kir6.2)
    Tammaro, Paolo
    CONGENITAL ENDOCRINOPATHIES: NEW INSIGHTS INTO ENDOCRINE DISEASES AND DIABETES, 2007, 11 : 70 - 82
  • [3] Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes
    Girard, Christophe A. J.
    Shimomura, Kenju
    Proks, Peter
    Absalom, Nathan
    Castano, Luis
    de Nanclares, Guiomar Perez
    Ashcroft, Frances M.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2006, 453 (03): : 323 - 332
  • [4] Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes
    Christophe A. J. Girard
    Kenju Shimomura
    Peter Proks
    Nathan Absalom
    Luis Castano
    Guiomar Perez de Nanclares
    Frances M. Ashcroft
    Pflügers Archiv, 2006, 453 : 323 - 332
  • [5] Efficacy of glibenclamide treatment in a child with permanent neonatal diabetes mellitus due to a KCNJ11 (Kir6.2) mutation
    Manna, Thais D.
    Battistim, Claudilene
    Radonsky, Vanessa
    Kuperman, Hilton
    Damiani, Durval
    Kok, Fernando
    Pearson, Ewan
    Hattersley, Andrew
    Reis, Andre F.
    HORMONE RESEARCH, 2008, 70 : 245 - 245
  • [6] Insulin independence with sulphonylurea treatment in a series of patients with permanent neonatal diabetes due to heterozygous activating mutations in the KCNJ11 (Kir6.2) gene
    Pearson, ER
    Flechtner, I
    Ellard, S
    Robert, JJ
    Clark, PM
    Hamilton-Shield, JP
    Polak, M
    Hattersley, AT
    DIABETOLOGIA, 2005, 48 : A113 - A114
  • [7] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2—initial and long-term response to sulfonylurea therapy
    Verena M. Wagner
    Britta Kremke
    Olaf Hiort
    Sarah E. Flanagan
    Ewan R. Pearson
    European Journal of Pediatrics, 2009, 168 : 359 - 361
  • [8] Successful transition from insulin to glyburide in 2 siblings with neonatal diabetes mellitus due to KCNJ11 gene mutation encoding Kir6.2
    Neacsu, Otilia
    Quintos, J. B.
    Phornphutkul, Chanika
    McEachern, Rebecca R.
    HORMONE RESEARCH, 2009, 72 : 327 - 327
  • [9] Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
    G. Tonini
    C. Bizzarri
    R. Bonfanti
    M. Vanelli
    F. Cerutti
    E. Faleschini
    F. Meschi
    F. Prisco
    E. Ciacco
    M. Cappa
    C. Torelli
    V. Cauvin
    S. Tumini
    D. Iafusco
    F. Barbetti
    Diabetologia, 2006, 49 : 2210 - 2213
  • [10] Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the β-cell potassium adenosine triphosphate channel
    Gloyn, AL
    Cummings, EA
    Edghill, EL
    Harries, LW
    Scott, R
    Costa, T
    Temple, IK
    Hattersley, AT
    Ellard, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3932 - 3935
12345